artesunic acid has been researched along with Alloxan Diabetes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, S; Li, J; Ma, C; Nong, X; Shi, R; Yuan, Z; Zhou, J | 1 |
| Fu, L; Jiang, H; Li, L; Li, S; Liu, J; Ma, Y; Peng, H; Yuan, J | 1 |
| Chen, Y; Li, J; Liang, C; Ma, L; Nong, X; Wang, B; Yang, S; Yuan, Z | 1 |
| Chen, Y; Li, J; Li, W; Liang, C; Lu, W; Nong, X; Wang, B; Yang, S; Yuan, Z | 1 |
| Chen, J; Chen, L; Li, L; Zhang, J; Zhou, Y | 1 |
| Huang, G; Li, Z; Liu, J; Shao, F; Shi, X; Zheng, P; Zhou, Z | 1 |
6 other study(ies) available for artesunic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Mechanism and effects of artesunate on the liver function of rats with type 1 diabetic periodontitis.
Topics: Animals; Artesunate; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Insulin; Liver; NF-kappa B; Periodontitis; Rats | 2022 |
Artesunate protects pancreatic β-cells from streptozotocin-induced diabetes via inhibition of the NLRP3/caspase-1/GSDMD pathway.
Topics: Animals; Artesunate; Caspase 1; Diabetes Mellitus, Experimental; Insulin-Secreting Cells; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphate-Binding Proteins; Pore Forming Cytotoxic Proteins; Streptozocin | 2022 |
Effect of artesunate on cardiovascular complications in periodontitis in a type I diabetes rat model and related mechanisms.
Topics: Alveolar Bone Loss; Animals; Artesunate; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dysbiosis; Humans; NF-kappa B; Periodontitis; Rats; Rats, Sprague-Dawley | 2023 |
Role of Artesunate on cardiovascular complications in rats with type 1 diabetes mellitus.
Topics: Animals; Aorta, Thoracic; Artesunate; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Hypoglycemic Agents; Lipids; Male; Myocardium; NF-kappa B; Organ Size; Rats; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Artesunate alleviates diabetic retinopathy by activating autophagy via the regulation of AMPK/SIRT1 pathway.
Topics: AMP-Activated Protein Kinases; Animals; Artesunate; Autophagy; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Rats; Sirtuin 1 | 2023 |
Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells.
Topics: Animals; Artesunate; CD8-Positive T-Lymphocytes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Insulin-Secreting Cells; Interferon-gamma; Interleukin-4; Interleukin-6; Mice; Mice, Inbred NOD; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha | 2019 |